Cargando…
Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target
Cryptococcus remains a leading cause of invasive fungal infections in immunocompromised people. Resistance to azole drugs has imposed a further challenge to the effective treatment of such infections. In this study, the functional expression of full-length hexahistidine-tagged Cryptococcus neoforman...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785471/ https://www.ncbi.nlm.nih.gov/pubmed/36547589 http://dx.doi.org/10.3390/jof8121256 |